Clearside Biomedical Statistics
Total Valuation
CLSDQ has a market cap or net worth of 4.13 million. The enterprise value is 58.95 million.
| Market Cap | 4.13M |
| Enterprise Value | 58.95M |
Important Dates
The next estimated earnings date is Wednesday, March 11, 2026.
| Earnings Date | Mar 11, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
CLSDQ has 5.23 million shares outstanding. The number of shares has increased by 9.72% in one year.
| Current Share Class | 5.23M |
| Shares Outstanding | 5.23M |
| Shares Change (YoY) | +9.72% |
| Shares Change (QoQ) | +0.86% |
| Owned by Insiders (%) | 13.24% |
| Owned by Institutions (%) | 13.69% |
| Float | 4.54M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.24 |
| PB Ratio | -0.08 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -2.27 |
| EV / Sales | 17.71 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -2.71 |
Financial Position
The company has a current ratio of 2.98
| Current Ratio | 2.98 |
| Quick Ratio | 2.55 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -2.83 |
| Interest Coverage | -2.17 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -70.35% |
| Return on Invested Capital (ROIC) | -125.63% |
| Return on Capital Employed (ROCE) | -258.84% |
| Revenue Per Employee | 104,031 |
| Profits Per Employee | -812,375 |
| Employee Count | 32 |
| Asset Turnover | 0.16 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, CLSDQ has paid 715,000 in taxes.
| Income Tax | 715,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -94.84% in the last 52 weeks. The beta is 1.87, so CLSDQ's price volatility has been higher than the market average.
| Beta (5Y) | 1.87 |
| 52-Week Price Change | -94.84% |
| 50-Day Moving Average | 3.28 |
| 200-Day Moving Average | 8.66 |
| Relative Strength Index (RSI) | 26.56 |
| Average Volume (20 Days) | 704,964 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.55 |
Income Statement
In the last 12 months, CLSDQ had revenue of 3.33 million and -26.00 million in losses. Loss per share was -5.05.
| Revenue | 3.33M |
| Gross Profit | 2.93M |
| Operating Income | -22.96M |
| Pretax Income | -25.28M |
| Net Income | -26.00M |
| EBITDA | -22.63M |
| EBIT | -22.96M |
| Loss Per Share | -5.05 |
Balance Sheet
The company has 6.80 million in cash and 61.61 million in debt, giving a net cash position of -54.81 million or -10.47 per share.
| Cash & Cash Equivalents | 6.80M |
| Total Debt | 61.61M |
| Net Cash | -54.81M |
| Net Cash Per Share | -10.47 |
| Equity (Book Value) | -53.95M |
| Book Value Per Share | -10.31 |
| Working Capital | 5.48M |
Cash Flow
In the last 12 months, operating cash flow was -21.29 million and capital expenditures -453,000, giving a free cash flow of -21.75 million.
| Operating Cash Flow | -21.29M |
| Capital Expenditures | -453,000 |
| Free Cash Flow | -21.75M |
| FCF Per Share | -4.15 |
Margins
| Gross Margin | 88.07% |
| Operating Margin | -689.76% |
| Pretax Margin | -759.42% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
CLSDQ does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -9.72% |
| Shareholder Yield | -9.72% |
| Earnings Yield | -628.71% |
| FCF Yield | -525.92% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on September 15, 2025. It was a reverse split with a ratio of 0.0666667.
| Last Split Date | Sep 15, 2025 |
| Split Type | Reverse |
| Split Ratio | 0.0666667 |
Scores
CLSDQ has an Altman Z-Score of -50.05 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -50.05 |
| Piotroski F-Score | 1 |